Vol 26, No 3 (2021)
Research paper
Published online: 2021-04-08

open access

Page views 1289
Article views/downloads 2850
Get Citation

Connect on Social Media

Connect on Social Media

Commissioning and quality assurance of HalcyonTM 2.0 linear accelerator

Pushpraj K. Pathak1, S.K. Vashisht1, S. Baby1, P.K. Jithin1, Y. Jain2, R. Mahawar2, V.G. G.K. Sharan2
Rep Pract Oncol Radiother 2021;26(3):433-444.


BACKGROUND: Varian Medical Systems has introduced a new medical linear accelerator called HalcyonTM 2.0, which is based on the ring delivery system (RDS). It is a true IGRT machine having 6MV FFF photon energy. In addition to the planar and MV-CBCT imaging techniques it also has an option of ultra-fast kV-iCBCT which enhances the image reconstruction and improves the visualization of soft tissue. The field portals are shaped by a unique dual layer MLC with special stacked and staggered design which enables high modulation with low radiation leakage. Recently, we have commissioned our first Halcyon 2.0 machine.

The aim of this work was to systematically investigate various parameters of a newly installed HalcyonTM 2.0 linear accelerator.

MATERIALS AND METHODS: Detailed measurements were conducted as per various guidelines. Also, the measurements were performed to fulfil the national regulatory requirements. Commissioning data of Halcyon 6 MV-FFF beam was performed in a water tank. For absolute measurements, a 0.6-cc waterproof Farmer chamber and electrometer were used. All relative measurements (PDDs, in-line, cross-line and angular profiles) were performed with 0.0125 cc point chamber.

RESULTS: All the tests were within the acceptable limit. Measured data were compared with factory data as well as the existing medical linear accelerator of the same category. The obtained results were quite satisfactory.

CONCLUSIONS: This study summarizes the commissioning experience with Halcyon linear accelerator. Evaluation of mechanical, radiation safety and dosimetric parameters were performed. The obtained parameters were well below the specified tolerance limits.

Article available in PDF format

View PDF Download PDF file


  1. Tsiamas P, Seco J, Han Z, et al. A modification of flattening filter free linac for IMRT. Med Phys. 2011; 38(5): 2342–2352.
  2. Georg D, Kragl G, Wetterstedt Saf, et al. Photon beam quality variations of a flattening filter free linear accelerator. Med Phys. 2010; 37(1): 49–53.
  3. Ceberg C, Johnsson S, Lind M, et al. Prediction of stopping-power ratios in flattening-filter free beams. Med Phys. 2010; 37(3): 1164–1168.
  4. Kragl G, Wetterstedt Saf, Knäusl B, et al. Dosimetric characteristics of 6 and 10MV unflattened photon beams. Radiother Oncol. 2009; 93(1): 141–146.
  5. Cashmore J. The characterization of unflattened photon beams from a 6 MV linear accelerator. Phys Med Biol. 2008; 53(7): 1933–1946.
  6. Titt U, Vassiliev ON, Pönisch F, et al. Monte Carlo study of backscatter in a flattening filter free clinical accelerator. Med Phys. 2006; 33(9): 3270–3273.
  7. Zhu XR, Kang Y, Gillin MT. Measurements of in-air output ratios for a linear accelerator with and without the flattening filter. Med Phys. 2006; 33(10): 3723–3733.
  8. Pönisch F, Titt U, Vassiliev ON, et al. Properties of unflattened photon beams shaped by a multileaf collimator. Med Phys. 2006; 33(6): 1738–1746.
  9. Vassiliev ON, Titt U, Kry SF, et al. Dosimetric properties of photon beams from a flattening filter free clinical accelerator. Phys Med Biol. 2006; 51(7): 1907–1917.
  10. Titt U, Vassiliev ON, Pönisch F, et al. A flattening filter free photon treatment concept evaluation with Monte Carlo. Med Phys. 2006; 33(6): 1595–1602.
  11. Feng Z, Yue H, Zhang Y, et al. Monte Carlo simulation of beam characteristics from small fields based on TrueBeam flattening-filter-free mode. Radiat Oncol. 2016; 11: 30.
  12. Halcyon Instruction for use. Varian Medical systems. Palo Alto, Jan 2018.
  13. Ding GX, Munro P. Radiation exposure to patients from image guidance procedures and techniques to reduce the imaging dose. Radiother Oncol. 2013; 108(1): 91–98.
  14. Glide-Hurst C, Bellon M, Foster R, et al. Commissioning of the Varian TrueBeam linear accelerator: a multi-institutional study. Med Phys. 2013; 40(3): 031719.
  15. Chang Z, Wu Q, Adamson J, et al. Commissioning and dosimetric characteristics of TrueBeam system: composite data of three TrueBeam machines. Med Phys. 2012; 39(11): 6981–7018.
  16. Lloyd SAM, Lim TY, Fave X, et al. TG-51 reference dosimetry for the Halcyon™: A clinical experience. J Appl Clin Med Phys. 2018; 19(4): 98–102.
  17. Li Y, Netherton T, Nitsch PL, et al. Independent validation of machine performance check for the Halcyon and TrueBeam linacs for daily quality assurance. J Appl Clin Med Phys. 2018; 19(5): 375–382.
  18. Halcyon Machine Performance Check Reference Guide. Varian Medical System 2018.
  19. Richart J, Pujades MC, Perez-Calatayud J, et al. QA of dynamic MLC based on EPID portal dosimetry. Phys Med. 2012; 28(3): 262–268.
  20. Venencia C, Besa P. Commissioning and quality assurance for intensity modulated radiotherapy with dynamic multileaf collimator: experience of the Pontificia Universidad Católica de Chile. J Appl Clin Med Phys. 2004; 5(3): 37–54.
  21. LoSasso T, Chui CS, Ling CC. Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. Med Phys. 1998; 25(10): 1919–1927.
  22. Pathak P, Vashisht S. A quantitative analysis of intensity-modulated radiation therapy plans and comparison of homogeneity indices for the treatment of gynaecological cancers. J Med Phys. 2013; 38(2): 67–73.
  23. Schneider U, Hälg R, Besserer J. Concept for quantifying the dose from image guided radiotherapy. Radiat Oncol. 2015; 10: 188.
  24. Musolino S. Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry Based on Standards of Absorbed Dose to Water; Technical Reports Series No. 398, Health Physics. 2001; 81(5): 592–593.
  25. Peter R, Peter J, Coursey BM. Report No. 067-AAPM’s TG- 51 protocol for clinical reference dosimetry of high- energy photon and electron beams. 1999.
  26. Pönisch F, Titt U, Vassiliev ON, et al. Properties of unflattened photon beams shaped by a multileaf collimator. Med Phys. 2006; 33(6): 1738–1746.
  27. Boyer A, Biggs P, Galvin J et al. Basic Applications of Multileaf Collimator: Report of Task Group No. 50 Radiation Therapy Committee. American Association of Physicists in Medicine (AAPM TG-50, 10) (AAPM Report No. 72), 2001. https://www.aapm.org/pubs/reports/detail.asp?docid=71.
  28. Ling C, Zhang P, Archambault Y, et al. Commissioning and Quality Assurance of RapidArc Radiotherapy Delivery System. Int J Radiat Oncol Biol Phys. 2008; 72(2): 575–581.
  29. Structural shielding design and evaluation for Megavoltage X and Gamma ray Radiotherapy facilities. National Commission on Radiation Protection Report 2005; No. 151. 2005.
  30. Klein EE, Hanley J, Bayouth J, et al. Task Group 142, American Association of Physicists in Medicine. Task Group 142 report: quality assurance of medical accelerators. Med Phys. 2009; 36(9): 4197–4212.
  31. Netherton T, Li Y, Gao S, et al. Experience in commissioning the halcyon linac. Med Phys. 2019; 46(10): 4304–4313.
  32. Gao S, Netherton T, Chetvertkov SA, et al. Acceptance and verification of the Halcyon Eclipse linear accelerator treatment planning system without 3D water scanning system. J Appl Clin Med Phys. 2019; 20(10): 111–117.

Reports of Practical Oncology and Radiotherapy